Company Performance Metrics
Kirby Cramer: Co-Chairman
Chris Rivera: Chief Executive Officer and PresidentPast Role: Genzyme, Sales, Marketing, Commercial Operations and Management
WINGS was formed at a CEO dinner in May 2009 to address what was identified as the #1 need in the Medical Technology Industry Cluster – local, smart, seed funding. Angel Investors get the best returns when they invest in their areas of expertise. WINGS is focused on closing the gap by bringing the wealth of Washington’s medical technology experts
to the arena of angel investing.
WINGS meetings are held 4 times a year, during which 3 to 4 business opportunities are presented. Any opportunity presented receives rigorous screening by a Committee composed of local Medical Technology experts. WINGS limits the opportunities it screens to Therapeutic and Diagnostic Devices, Healthcare IT, Healthcare Delivery Models and unregulated biotechnology development tools.
